Mainstream News

FDA backs Pfizer COVID-19 boosters for seniors, high-risk

FDA backs Pfizer COVID-19 boosters for seniors,
high-risk 1

The CDC panelists heard a series of presentations Wednesday outlining the knotty state of science on boosters. On one hand, the COVID-19 vaccines continue to offer strong protection against severe illness, hospitalization and death. On the other hand, there are signs of more low-grade infections among the vaccinated as immunity wanes.

Read the Full Article

Mainstream News

Prepare Now Before its too Late

Discover where products are available & compare prices

FDA approves Pfizer COVID-19 boosters for seniors, high-risk
FDA backs Pfizer COVID-19 boosters for seniors, high-risk

You might also like
Menu